Early Driver of Prostate Cancer Aggressiveness

Early driver of prostate cancer aggressiveness

Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.

Researchers find early driver of prostate cancer aggressiveness

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.

Scientists Identify Early Indicator of Prostate Cancer Aggressiveness

In a groundbreaking study that could reshape the understanding and treatment of aggressive prostate cancer, researchers at the University of Michigan Rogel Cancer Center have identified a pivotal gene implicated in the transition of prostate tumor cells into lethal, treatment-resistant forms. This discovery centers around the gene PROX1, which has been shown to drive a cellular transformation process known as lineage plasticity, ultimately contr…